These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years. Onuma Y; Honda Y; Asano T; Shiomi H; Kozuma K; Ozaki Y; Namiki A; Yasuda S; Ueno T; Ando K; Furuya J; Hanaoka KI; Tanabe K; Okada K; Kitahara H; Ono M; Kusano H; Rapoza R; Simonton C; Popma JJ; Stone GW; Fitzgerald PJ; Serruys PW; Kimura T JACC Cardiovasc Interv; 2020 Jan; 13(1):116-127. PubMed ID: 31918929 [TBL] [Abstract][Full Text] [Related]
25. First Bioresorbable Vascular Scaffold Implantation in Patients with Acute Coronary Syndrome in the Republic of Macedonia. Kostov J; Davceva-Pavlovska J; Kedev S Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):147-55. PubMed ID: 27442381 [TBL] [Abstract][Full Text] [Related]
26. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction. Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294 [TBL] [Abstract][Full Text] [Related]
27. Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent. Dalos D; Gangl C; Roth C; Krenn L; Scherzer S; Vertesich M; Lang I; Maurer G; Neunteufl T; Berger R; Delle-Karth G BMC Cardiovasc Disord; 2016 May; 16():104. PubMed ID: 27225486 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436 [TBL] [Abstract][Full Text] [Related]
30. Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds. Caiazzo G; Longo G; Giavarini A; Kilic ID; Fabris E; Serdoz R; Mattesini A; Foin N; Secco GG; De Rosa S; Indolfi C; Di Mario C Int J Cardiol; 2016 Oct; 221():352-8. PubMed ID: 27404705 [TBL] [Abstract][Full Text] [Related]
31. Optical Coherence Tomography for Coronary Bioresorbable Vascular Scaffold Implantation: A Randomized Controlled Trial. Lee SY; Kang DY; Hong SJ; Ahn JM; Ahn CM; Park DW; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Park SJ; Hong MK Circ Cardiovasc Interv; 2020 Jan; 13(1):e008383. PubMed ID: 32525410 [TBL] [Abstract][Full Text] [Related]